Evolution of Approaches to Therapeutic Prevention and Treatment of the New Coronavirus Infection
- PMID: 36091845
- PMCID: PMC9447967
- DOI: 10.1134/S1019331622040049
Evolution of Approaches to Therapeutic Prevention and Treatment of the New Coronavirus Infection
Abstract
The means of drug intervention for the prevention and treatment of new coronavirus infection (COVID-19) are discussed. Changes in approaches aimed at the main links of pathogenesis and capable of positively influencing the course and outcome of the disease that have been implemented after the appearance of the results of numerous randomized trials are presented. Some aspects of the ongoing study of the problem are characterized.
Keywords: COVID-19; new coronavirus infection; prevention; treatment.
© Pleiades Publishing, Ltd. 2022, ISSN 1019-3316, Herald of the Russian Academy of Sciences, 2022, Vol. 92, No. 4, pp. 430–436. © Pleiades Publishing, Ltd., 2022.Russian Text © The Author(s), 2022, published in Vestnik Rossiiskoi Akademii Nauk, 2022, Vol. 92, No. 7, pp. 691–698.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4. Trials. 2020. PMID: 32493478 Free PMC article.
-
A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).Trials. 2021 Jan 6;22(1):23. doi: 10.1186/s13063-020-04939-2. Trials. 2021. PMID: 33407828 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Coronavirus Disease 2019: Clinics, Treatment, and Prevention.Front Microbiol. 2021 Nov 11;12:761887. doi: 10.3389/fmicb.2021.761887. eCollection 2021. Front Microbiol. 2021. PMID: 34858373 Free PMC article. Review.
-
Pathogenesis-directed therapy of 2019 novel coronavirus disease.J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33073355 Review.
References
-
- S. N. Avdeev, L. T. Adamyan, E. I. Alekseeva, et al., Prevention, Diagnosis, and Treatment of Novel Coronavirus Infection (COVID-19): Temporary Guidelines, Version 14 (December 27, 2021) (Ministerstvo Zdravookhraneniya Rossiiskoi Federatsii, Moscow, 2021). https://cтoпкopoнaвиpyc.pф/ai/doc/1213/attach/ vmr_COVID-19_V14_27-12-2021.pdf
-
- O. M. Drapkina, A. Yu. Gorshkov, Yu. V. Yakimov, et al., The Procedure for Vaccination against a New Coronavirus Infection (COVID-19): Temporary Guidelines, Version Dated December 22, 2021 (Ministerstvo Zdravookhraneniya Rossiiskoi Federatsii, Moscow, 2021). https://www.consultant.ru/document/cons_doc_ LAW_404645/
LinkOut - more resources
Full Text Sources